Home  >  News
you can get e-magazine links on WhatsApp.Click here
  Oncolytics’ partner Adlai Nortye advances to second dose escalation cohort of Chinese bridging trial of pelareorep-paclitaxel combo to treat breast cancer,   January 28, 2022
  Mix-and-match trial finds additional dose of Covid-19 vaccine safe, immunogenic,   January 28, 2022
  NIH-funded preclinical study identifies potential therapeutic approach to treat ALS,   January 27, 2022
  Natera presents positive data from CIRCULATE-Japan study of tumour-informed MRD test, Signatera at ASCO GI symposium,   January 25, 2022
  Harbour BioMed begins patient dosing in phase Ib/IIa trial of next-generation anti-CTLA-4 antibody,   January 25, 2022
  BeiGene phase 3 trial of tislelizumab in combo with chemotherapy in first-line gastric or gastroesophageal junction cancer meets primary endpoint,   January 25, 2022
  Verona Pharma completes patient enrollment in phase 3 ENHANCE-2 trial of ensifentrine for maintenance treatment of COPD,   January 25, 2022
  Bio-Thera begins patient dosing in Australia for BAT6021 to treat solid tumours,   January 25, 2022
  Ascletis begins patient dosing in phase III trial of FASN inhibitor ASC40 in combo with bevacizumab to treat recurrent glioblastoma,   January 24, 2022
  US FDA lifts partial clinical hold on Kura Oncology’s KOMET-001 phase 1b study of KO-539 to treat AML,   January 24, 2022
  UCB announces result from phase 3 BE COMPLETE study of Bimzelx to treat active psoriatic arthritis,   January 24, 2022
  NIH funded clinical trial finds oral immunotherapy induces remission of peanut allergy in some young children,   January 24, 2022
  Oncolytics Biotech provides enrollment update on multi-indication phase 1/2 gastrointestinal cancer trial at 2022 ASCO-GI symposium,   January 22, 2022
  AffaMed begins patient dosing in clinical trial of Dextenza to treat ocular inflammation and pain post-cataract surgery,   January 21, 2022
  SMT announces positive results from Hydra transcatheter aortic heart valve,   January 21, 2022
  Hutchmed begins phase I trial of HMPL-653 to treat advanced malignant solid tumours and TGCT,   January 21, 2022
  Curcumin extract shows positive results and pain-relief benefits in knee osteoarthritis trial,   January 20, 2022
  Merck announces phase 3 KEYNOTE-394 trial of Keytruda significantly improve OS vs placebo in certain patients with advanced HCC previously treated with sorafenib,   January 20, 2022
  Sanofi, Regeneron announce second phase 3 trial of Dupixent to treat prurigo nodularis met primary and key secondary endpoints,   January 20, 2022
  Alligator reports update on-going OPTIMIZE-1 phase Ib/II trial with mitazalimab,   January 19, 2022

Copyright © 2016 Saffron Media Pvt. Ltd |